In addition, we evaluated whether SLPI expression also had prognostic value independently of clinical risk factors in stage III CRC patients with MSS tumors who received adjuvant chemotherapy, as in these patients high SLPI expression was associated with reduced disease recurrence. The gene discussed is SLPI; the disease is colorectal carcinoma.